News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

July 15, 2022

Ongoing Smoke Free Support Study 2.0 featured in BioMed Central’s Public Health Journal

July 14, 2022

Media Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial

July 2, 2022

What is ECOG-ACRIN EA2142? And why should you care?

June 28, 2022

The Summer 2022 advocacy blog, Considering Clinical Trials, is now available

June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

June 20, 2022

TMIST breast cancer trial looks to recruit underserved communities

June 7, 2022

Pancreatic neuroendocrine tumors: Capecitabine plus temozolomide gives longer PFS than temozolomide alone

June 7, 2022

E2108 evidence informs a discussion on systemic therapy vs surgery for de novo stage IV breast cancer

June 6, 2022

Novel drug combination demonstrates promising results in treating pancreatic neuroendocrine tumors

June 6, 2022

E2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors

June 6, 2022

Dr. Michael Atkins discusses the DREAMseq trial in patients with advanced melanoma

June 5, 2022

Dr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine

June 5, 2022

Drug combination shows promise for treating pancreatic neuroendocrine tumors

June 4, 2022

E3311: No differences in survival outcomes based on tobacco history in HPV-associated head and neck cancer

June 1, 2022

Precision medicine clinical trials: A conversation between Peter O’Dwyer and Lale Kostakoglu

May 27, 2022

Press Release: ECOG-ACRIN research highlights at ASCO 2022

May 19, 2022

Dr. Alicia Morgans on going beyond ADT for metastatic prostate cancer

May 17, 2022

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio

May 5, 2022

The current state of metastatic melanoma (a series of four videos)

May 4, 2022

Dr. Kevin Kalinsky discusses updates from the TAILORx breast cancer trial

 
ECOG-ACRIN Cancer Research Group